If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

A Sequence-Specific RNase Activity Derived from the Interface of the Dimeric Immunity Protein of the ColE7 Operon

$63.10 plus tax (Refund Policy)

Buy Article:

Abstract:

Recently, two sequence-specific cleavage sites were found in the ceiE7 gene of the cea-cei-cel polycistronic transcript from the ColE7 operon. The crystal structure of the ColE7 immunity protein (ImE7) suggested that a novel ribonuclease active site is created at the interface of the dimeric structure of the protein. Frame shift mutation of the ceiE7 gene and mutation of histidine residues at the putative active site of the dimeric ImE7 protein respectively abolished and significantly reduced the observed ribonucleolytic cleavage indicating that the dimeric ImE7 protein is indeed involved in this sequence-specific cleavage at the ceiE7 mRNA. It is noteworthy that E. coli S-30 cell extracts must be added to the in vitro reactions in order to detect this ribonucleolytic cleavage. In addition, mutation of the T1 stem-loop structure located between the ceiE7 and the celE7 genes completely turned off the ribonuclease activity in vivo, implying that the T1 stemloop structure might participate in mediating the formation of a degradosome-like complex required for this specific ribonucleolytic activity.





Keywords: ColE7 operon; ImE7 protein; degradosome; dimeric structure; sequence-specific cleavage; stem-loop

Document Type: Research Article

DOI: http://dx.doi.org/10.2174/092986607779816041

Affiliations: Institute of Biochemistry,National Yang Ming University, No. 155, section 2, Li-Nong street, Pei-Tou, Taipei 11221, Taiwan.

Publication date: February 1, 2007

More about this publication?
  • Protein & Peptide Letters publishes short papers in all important aspects of protein and peptide research, including structural studies, recombinant expression, function, synthesis, enzymology, immunology, molecular modeling, drug design etc. Manuscripts must have a significant element of novelty, timeliness and urgency that merit rapid publication. Reports of crystallisation, and preliminary structure determinations of biologically important proteins are acceptable. Purely theoretical papers are also acceptable provided they provide new insight into the principles of protein/peptide structure and function.
Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more